Flow Cytometry Market Global Trends, Market Share, Industry Size, Growth, Opportunities, and Market

Global flow cytometry market is estimated to value over USD 6.3 billion and register a CAGR of over 8% during the forecast period 2019 to 2026.

Flow cytometry is a tool used for detecting physicochemical properties of a cell or particles, based on the principle of light scattering. Cell counting, cell sorting, detection of microbes, protein engineering detection, etc. are some of the uses of flow cytometry.

The advancements in technology, adoption of flow cytometry method in research and academics, initiatives in oncology and immunology research, etc. are the driving factors aiding the flow cytometry market to grow. The inclination towards adopting a more effective alternative for diagnosis of severe diseases has boosted market demand for flow cytometry techniques.

Being an advanced system, the flow cytometry should be operated by well trained and skilled personnel. The equipment maintenance expenses and expenditure assigned on personnel training are quite high resulting in limited purchasing by the majority of end users. These factors are estimated to affect market growth.

The cell-based flow cytometry is estimated to dominate the market. In the current era, owing to the rising focus on cell culture, target enrichment, deep cell diagnosis, isolation of cytoplasmic contents and proteins, etc. the investments and expenditure on cell-based research have increased significantly. Thus, it is an integral factor responsible for the proliferation of the segment.

The research organizations are focusing on finding a better alternative for current cell analytical techniques. Flow cytometry is a major tool for in-depth study and development of cell-based assays. Research and academic institutes tend to invest more in the flow cytometry market, this is driving market growth.

Initiatives for adopting advanced flow cytometry techniques and products are undertaken on a larger scale in North America. The market is boosted by the funds from the private and public sectors in this region. Furthermore, Europe has a large amount of outsourcing for clinical products by flow cytometry resulting in rising market share.

The key market players are Agilent Technologies, Apogee Flow Systems, Beckman Coulter (A Subsidiary of Danaher), Cytonome St, Thermo Fisher Scientific, etc. Agilent Technologies and Thermo Fisher Scientific are expected to have a major market share owing to advanced equipment and methods.

Request a Sample Report @ https://www.futurewiseresearch.com/request-sample.aspx?id=3382&page=requestsample

FutureWise Key Takeaways:

• Investment in cell-based oncology and immunology research
• Collaboration with research organizations
• Development of advanced and affordable equipment

Global Flow Cytometry Market Segmentation:

By Technology:

• Cell-based flow cytometry
• Bead-based flow cytometry

By Product and Service:

• Reagents and consumables
• Flow cytometry instruments
• Services
• Softwares
• Accessories

By Application:

• Research applications
• Clinical applications
• Industrial applications

By End User:

• Academic and research institutes
• Hospitals and clinical testing laboratories
• Pharmaceutical and biotechnology companies

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Purchase a Copy of this Premium Research Report & Ask For Discount: https://www.futurewiseresearch.com/request-sample.aspx?id=3382&page=askfordiscount

Competitive Landscape:

• Tier 1 players- established companies in the market with a major market share
• Tier 2 players
• Emerging players which are growing rapidly
• New Entrants

Objectives of the Study:

• To provide with an exhaustive analysis on the flow cytometry market by technology, by product and service, by application, by end user and by region
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions (along with countries)— North America, Asia Pacific, Europe, Latin America and Middle East and Africa
• To record evaluate and competitive landscape mapping-product launches, technological advancements, mergers, and expansions
• Profiling of companies to evaluate their market shares, strategies, financials, and core competencies

Table of Contents

1 Introduction

1.1 Objectives of the Study

1.2 Market Definition

1.3 Study Scope

1.3.1 Markets Covered

1.3.2 Years Considered for the Study

1.4 Currency Used for the Study

1.5 Stakeholders

2 Research Methodology

2.1 Research Data

2.1.1 Secondary Data

2.1.1.1 Key Data From Secondary Sources

2.1.2 Primary Data

2.1.2.1 Key Data From Primary Sources

2.1.2.2 Breakdown of Primaries

2.2 Market Estimation Methodology

2.2.1 Revenue Mapping-Based Market Estimation

2.2.2 Usage-Based Market Estimation

2.2.3 Primary Research Validation

2.3 Data Triangulation Methodology

2.4 Research Assumptions

2.5 Research Limitations

3 Executive Summary

4 In-Depth Insights

4.1 Flow Cytometry: Market Overview

4.2 Flow Cytometry Market, By Product & Service, 2018 vs 2026

4.3 Flow Cytometry Market, By Application, 2018 vs 2026 (USD Million)

4.4 Flow Cytometry Market, By End User, 2018 vs 2026

4.5 Geographical Snapshot of the Flow Cytometry Market

5 Market Overview

5.1 Introduction

5.2 Market Dynamics

5.2.1 Drivers

5.2.1.1 Technological Advancements

5.2.1.2 Increasing Adoption of Flow Cytometry Techniques in Research and Academia

5.2.1.3 Growing Public-Private Initiatives in the Field of Immunology and Immuno-Oncology Researches

5.2.1.4 Rising Global Incidence and Prevalence of Hiv/Aids and Cancer

5.2.1.5 Increased Availability of Application-Specific Products

5.2.2 Restraints

5.2.2.1 Significant Product Costs

5.2.2.2 Dearth of Well-Trained and Skilled Professionals

5.2.3 Opportunities

5.2.3.1 Growing Market Presence in Emerging Countries

5.2.3.2 Evolving Pipeline for Stem Cell Research

5.2.3.3 Adoption of Recombinant Dna Technology for Antibody Production

5.2.3.4 Advent of Tandem Flow Cytometry Technologies

5.2.4 Challenges

5.2.4.1 Inadequate Research Infrastructure Across Emerging Countries

5.2.4.2 Complexities Related to Reagent Development

5.2.4.3 Limited Purchasing Power of Majority of End Users in Emerging Countries

5.3 Regulatory Challenges

5.3.1 Stringent Fda Requirements

5.3.2 Stringent Analyte-Specific Reagent (ASR) Rule

5.3.3 Lack of Well-Defined Validation Protocols for Cell-Based Assays

5.3.4 Absence of Established Laboratory-Developed Test (LDT) Guidelines on Cell-Based Fluorescence Assays

5.3.5 Greater Global Recognition for Ivd–Ce Mark Approvals

5.4 U.S. Reimbursement Scenario

6 Flow Cytometry Market, By Technology

6.1 Introduction

6.2 Cell-Based Flow Cytometry

6.2.1 Cell-Based Technologies to Dominate the Global Market Till 2026

6.3 Bead-Based Flow Cytometry

6.3.1 Procedural Advantages to Drive the Market Growth for Bead-Based Flow Cytometry Segment

7 Flow Cytometry Market, By Product & Service

7.1 Introduction

7.2 Reagents and Consumables

7.2.1 Flow Cytometry Reagents and Consumables Market Split, By Application

7.2.2 Flow Cytometry Reagents and Consumables Market Split, By Research Application

7.2.3 Flow Cytometry Reagents and Consumables Market Split, By Clinical Application

7.2.4 Flow Cytometry Reagents and Consumables Market Split, By End User

7.3 Flow Cytometry Instruments

7.3.1 Flow Cytometry Instruments Market Split, By Application

7.3.2 Flow Cytometry Instruments Market Split, By Research Application

7.3.3 Flow Cytometry Instruments Market Split, By Clinical Application

7.3.4 Flow Cytometry Instruments Market Split, By End User

7.3.5 Cell Analyzers

7.3.5.1 Flow Cytometry Based Cell Analyzers Market Split, By Application

7.3.5.2 Flow Cytometry Based Cell Analyzers Market Split, By Research Application

7.3.5.3 Flow Cytometry Based Cell Analyzers Market Split, By Clinical Application

7.3.5.4 Flow Cytometry Based Cell Analyzers Market Split, By End User

7.3.5.5 High-Range Cell Analyzers

7.3.5.5.1 High-Range Cell Analyzers Account for the Largest Share of the Cell Analyzers Market

7.3.5.6 Mid-Range Cell Analyzers

7.3.5.6.1 Wide Availability of Compact and High-Performance Analyzers in This Price Range Support Market Growth

7.3.5.7 Low-Range Cell Analyzers

7.3.5.7.1 Low-Range Analyzers Find Significant Adoption Among Price-Sensitive End Users

7.3.6 Cell Sorters

7.3.6.1 Flow Cytometry Based Cell Sorters Market Split, By Application

7.3.6.2 Flow Cytometry Based Cell Sorters Market Split, By Research Application

7.3.6.3 Flow Cytometry Based Cell Sorters Market Split, By Clinical Application

7.3.6.4 Flow Cytometry Based Cell Sorters Market Split, By End User

7.3.6.5 High-Range Cell Sorters

7.3.6.5.1 High-Range Cell Sorters Dominate the Market

7.3.6.6 Mid-Range Cell Sorters

7.3.6.6.1 Product Launches and A Balance Between Efficiency and Costs Have Enabled the Growth of This Market Segment

7.3.6.7 Low-Range Cell Sorters

7.3.6.7.1 Increasing Commercialization of Affordable Products has Driven Adoption of Low-Range Cell Sorters

7.4 Services

7.4.1 Flow Cytometry Services Market Split, By Application

7.4.2 Flow Cytometry Services Market Split, By Research Application

7.4.3 Flow Cytometry Services Market Split, By Clinical Application

7.4.4 Flow Cytometry Services Market Split, By End User

7.5 Software

7.5.1 Flow Cytometry Software Market Split, By Application

7.5.2 Flow Cytometry Software Market Split, By Research Application

7.5.3 Flow Cytometry Software Market Split, By Clinical Application

7.5.4 Flow Cytometry Software Market Split, By End User

7.6 Accessories

7.6.1 Flow Cytometry Accessories Market Split, By Application

7.6.2 Flow Cytometry Accessories Market Split, By Research Application

7.6.3 Flow Cytometry Accessories Market Split, By Clinical Application

7.6.4 Flow Cytometry Accessories Market Split, By End User

8 Flow Cytometry Market, By Application

8.1 Introduction

8.2 Research Applications

8.2.1 Pharmaceuticals & Biotechnology

8.2.1.1 Drug Discovery

8.2.1.1.1 Wide Usage of Flow Cytometry in Drug Discovery is the Primary Driver of Market Growth

8.2.1.2 Stem Cell Research

8.2.1.2.1 Accuracy and Precision of Flow Cytometry Have Made It A Prominent Tool in Stem Cell Research

8.2.1.3 in Vitro Toxicity Testing

8.2.1.3.1 Need to Reduce Time and Cost of Drug Development Processes Will Be A Key Factor Driving Market Growth

8.2.2 Immunology

8.2.2.1 Flow Cytometry Plays A Vital Role in Immunology Studies

8.2.3 Cell Sorting

8.2.3.1 The Increase in Cell-Based Research Activity has Boosted Growth in This Application Segment

8.2.4 Apoptosis

8.2.4.1 Flow Cytometry Techniques are Used to Identify Changes Occurring During Apoptosis

8.2.5 Cell Cycle Analysis

8.2.5.1 Any Abnormality in Dna Content Can Be Detected Using Flow Cytometry

8.2.6 Cell Viability

8.2.6.1 Cell Viability is A Key Parameter Studied Using Flow Cytometry

8.2.7 Cell Counting

8.2.7.1 Flow Cytometry Allows for Easy Differentiation of Cells Via Scattering Or Staining

8.2.8 Other Research Applications

8.3 Clinical Applications

8.3.1 Cancer

8.3.1.1 Cancer Applications Include Determination of Tumor Malignancy and Chromosome Enumeration

8.3.2 Hematology

8.3.2.1 Flow Cytometry Can Help Identify A Wide Variety of Cell Surfaces and Cytoplasmic Antigens

8.3.3 Immunodeficiency Diseases

8.3.3.1 Flow Cytometry Allows for Simultaneous, Multi-Parameter Cell Analysis

8.3.4 Organ Transplantation

8.3.4.1 Use of Flow Cytometry to Reduce Organ Rejection Rates has Contributed to Market Growth

8.3.5 Other Clinical Applications

8.4 Industrial Applications

8.4.1 Wide End User Base to Drive Industrial Application Market Growth

9 Flow Cytometry Market, By End User

9.1 Introduction

9.2 Academic and Research Institutes

9.2.1 Strengthening Research Pipeline and Industry-Academia Collaboration to Drive the Market Growth

9.3 Hospitals & Clinical Testing Laboratories

9.3.1 Rising Awareness and Disease Prevalence Have Sustained the Demand for Flow Cytometry

9.4 Pharmaceutical & Biotechnology Companies

9.4.1 Growing Drug Discovery Activity to Drive Market Growth

10 Flow Cytometry Market, By Region

10.1 Introduction

10.2 North America

10.2.1 US

10.2.1.1 High Adoption of Advanced Flow Cytometry Products Among End Users to Drive Market Growth in the Us

10.2.2 Canada

10.2.2.1 Availability of Public and Private Funding for Research Activities to Boost the Demand for Flow Cytometry Products in Canada

10.3 Europe

10.3.1 Germany

10.3.1.1 Greater Outsourcing of Clinical Diagnostic Services to Be the Key Trend in the German Flow Cytometry Market

10.3.2 UK

10.3.2.1 UK to Witness Growing Acceptance of Flow Cytometry Products for Clinical Diagnostics

10.3.3 France

10.3.3.1 Training and Awareness Programs By Social Organizations and Key Players Expected to Fuel the Adoption of Flow Cytometry

10.3.4 Rest of Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.1.1 Strong Infrastructure and Favorable Market Outlook Have Sustained Japan’s Dominance in the APAC Market

10.4.2 China

10.4.2.1 China Accounts for the Second-Largest Share in the APAC Market

10.4.3 India

10.4.3.1 High Incidence of Hiv/Aids and Cancer to Drive the Demand for Flow Cytometry Instruments in India

10.4.4 Rest of Asia Pacific

10.5 Latin America

10.5.1 Brazil

10.5.1.1 Brazil Dominates the Latam Market for Flow Cytometry

10.5.2 Mexico

10.5.2.1 Free Trade Agreements Will Support Imports, Accessibility to Flow Cytometry Instruments in Mexico

10.5.3 Rest of Latin America

10.6 Middle East and Africa

10.6.1 Low Disposable Income and Need for Infrastructural Development Hinder Market Growth

11 Competitive Landscape

11.1 Overview

11.2 Global Market Share Analysis (2018)

11.3 Competitive Scenario

11.3.1 Key Product Launches and Approvals (2014–2018)

11.3.2 Key Agreements, Partnerships, and Collaborations (2014–2018)

11.3.3 Key Acquisitions (2014–2018)

11.3.4 Key Expansions (2014–2018)

11.4 Competitive Leadership Mapping

11.4.1 Competitive Leadership Mapping: Major Market Players (2018)

11.4.1.1 Vanguards

11.4.1.2 Innovators

11.4.1.3 Dynamic Players

11.4.1.4 Emerging Companies

11.4.2 Competitive Leadership Mapping: Emerging Companies/SMEs/Start-UPS (2018)

11.4.2.1 Progressive Companies

11.4.2.2 Starting Blocks

11.4.2.3 Responsive Companies

11.4.2.4 Dynamic Companies

12 Company Profiles

(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, FutureWise Perspective)

12.1 Agilent Technologies

12.2 Apogee Flow Systems

12.3 Beckman Coulter (A Subsidiary of Danaher)

12.4 Becton, Dickinson and Company

12.5 Biomérieux S.A.

12.6 Bio-Rad Laboratories

12.7 Cytonome St

12.8 Enzo Life Sciences (A Wholly Owned Subsidiary of Enzo Biochem, Inc.)

12.9 Luminex

12.10 Merck KGaA

12.11 Miltenyi Biotec

12.12 Sony Biotechnology (A Wholly Owned Subsidiary of Sony Corporation of America)

12.13 Stratedigm

12.14 Sysmex Partec (A Subsidiary of Sysmex Corporation)

12.15 Thermo Fisher Scientific

13. Assumptions and Acronyms

14. Research Methodology

15. List of Sources of Information (Primary and Secondary)

Inquire further details about this report at: sales@futurewiseresearch.com

About FutureWise Research:

We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients. Through in-depth market insights and consultancy, we present our clients with the tools they need to be at the forefront of their industry – a position secured for far more than the near future.

Contact Us:

Company Name: FutureWise Research

Contact Person: Vinay Thaploo

Email: sales@futurewiseresearch.com

Phone: +44 141 628 9353 / +1 970 279 4295

City: Leeds

Country: United Kingdom

Website: www.futurewiseresearch.com

About FutureWise Research: We specialise in high-growth niche markets, assuring flexibility, agility and customised solutions for our clients.